Literature DB >> 9315447

The nitric oxide hypothesis of brain aging.

S M McCann1.   

Abstract

Nitric oxide synthase (NOS)-containing neurons are found in many loci throughout the central nervous system, which include the cerebral cortex, the cerebellum, the hippocampus, and the hypothalamus. NO plays a very important role in control of neuronal activity in all of these areas by diffusing into neurons where it activates soluble guanylate cyclase (sGC) leading to generation of cyclic guanosine monophosphate (cGMP) and cyclooxygenase 1 leading to generation of prostaglandins. Both of these active agents are involved in mediating the actions of NO, the first gaseous transmitter. In the cerebellum, NO is extremely important and it is also thought to mediate long-term potentiation in the hippocampus. Various stresses and corticoids have been shown in monkeys and also in rodents to cause neuronal cell death. This may be via the stimulation of glutamic acid release, which by N-methyl-D-aspartate (NMDA) receptors causes release of NO, which can lead to neuronal cell death. In the hypothalamus,. NO stimulates corticotropin-releasing hormone (CRH), prolactin releasing factor, growth hormone-releasing hormone (GHRH), and somatostatin, lutenizing hormone-releasing hormone (LHRH), but not follicle stimulating hormone-releasing factor (FSHRF) release. In situations of increased release of NO in the hypothalamus, it could cause neuronal cell death. Following bacterial or viral infections, toxic products of the ineffective agents, such as bacterial lipopolysaccharide (LPS), circulate to the brain, where they induce interleukin-1 and iNOS mRNA and synthesis. After several hours delay, massive quantities of NO are released. Induction of iNOS occurs in the choroid plexus, meninges, in circumventricular organs, and in large numbers of iNOS neurons in the arcuate and paraventricular nuclei. The large amounts of NO released by iNOS may well produce death not only of neurons but also glial. Repeated bouts of systemic infection even without direct neural involvement could result in induction of iNOS in the central nervous system and lead to large fall out of neurons in hippocampus to impair memory, hypothalamus to decrease fever, and neuroendocrine response to infection, and could play a role in the pathogenesis of degenerative neuronal diseases of aging, such as Alzheimers. The largest induction of iNOS occurs in the anterior pituitary and pineal glands. The damage to the pituitary could also impair responses to stress and infection, and the release of NO during infection could be responsible for the degenerative changes in the pineal and diminished release of melatonin, an antioxident, and consequently, an antiaging hormone, that occur with age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315447     DOI: 10.1016/s0531-5565(96)00154-4

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  20 in total

Review 1.  NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance.

Authors:  V Calabrese; T E Bates; A M Stella
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Research progress on neurobiology of neuronal nitric oxide synthase.

Authors:  Chun-Xia Luo; Dong-Ya Zhu
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

3.  Amelioration of age associated neuroinflammation on long term bacosides treatment.

Authors:  Manisha Rastogi; Rudra P Ojha; B Parimala Devi; Aabha Aggarwal; Aruna Agrawal; G P Dubey
Journal:  Neurochem Res       Date:  2011-12-25       Impact factor: 3.996

Review 4.  The hippocampus and cognitive impairments.

Authors:  E B Arushanyan; E V Beier
Journal:  Neurosci Behav Physiol       Date:  2008-10

Review 5.  Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.

Authors:  Katarzyna Urszula Domek-Łopacińska; Joanna B Strosznajder
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

6.  Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

7.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

Review 8.  Glial cell dysregulation: a new perspective on Alzheimer disease.

Authors:  Rommy von Bernhardi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

9.  Normal aging involves modulation of specific inflammatory markers in the rat retina and choroid.

Authors:  Jena J Steinle; Sheena Sharma; Christopher P Smith; Lisa S McFayden-Ketchum
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

10.  Study of the nitric oxide system in the rat cerebellum during aging.

Authors:  Santos Blanco; Francisco J Molina; Lourdes Castro; Maria L Del Moral; Raquel Hernandez; Ana Jimenez; Alma Rus; Esther Martinez-Lara; Eva Siles; Maria A Peinado
Journal:  BMC Neurosci       Date:  2010-06-24       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.